Zoetis Swine — Revenue decreased by 1.6% to $123.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from $111.00M to $123.00M. Over 4 years (FY 2021 to FY 2025), Swine — Revenue shows a downward trend with a -8.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests growing market penetration or higher demand for swine health solutions, while a decrease may indicate market contraction, competitive pressure, or reduced livestock production cycles.
This metric represents the total net sales generated from the sale of health products, including vaccines, parasiticides...
Comparable to livestock or production animal health revenue segments reported by other global animal health or pharmaceutical companies.
zts_segment_swine_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $161.00M | $153.00M | $155.00M | $154.00M | $144.00M | $129.00M | $138.00M | $142.00M | $133.00M | $129.00M | $139.00M | $127.00M | $130.00M | $131.00M | $128.00M | $111.00M | $119.00M | $111.00M | $125.00M | $123.00M |
| QoQ Change | — | -5.0% | +1.3% | -0.6% | -6.5% | -10.4% | +7.0% | +2.9% | -6.3% | -3.0% | +7.8% | -8.6% | +2.4% | +0.8% | -2.3% | -13.3% | +7.2% | -6.7% | +12.6% | -1.6% |
| YoY Change | — | — | — | — | -10.6% | -15.7% | -11.0% | -7.8% | -7.6% | +0.0% | +0.7% | -10.6% | -2.3% | +1.6% | -7.9% | -12.6% | -8.5% | -15.3% | -2.3% | +10.8% |